Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Efficacy of Intranasal Oxytocin for the Prevention of Postpartum Depression and PTSD

NCT02505984 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02505984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Efficacy of Intranasal Oxytocin for the Prevention of Postpartum Depression and PTSD
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
May 31, 2023
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, postpartum